Zenegra
Designed to support erectile capability to manage physical performance and alleviate pelvic vascular constriction.
- Category
- Erectile Dysfunction
- Active ingredient
- Sildenafil
- Route
- Oral use
- Form
- Tablet
- Strengths
- 50mg · 100mg
Prescription and consultation requirements for Zenegra vary by destination and are determined by the fulfilment partner.
Zenegra details
- Condition
- Erectile Dysfunction
- Alternative names
- sildenafil
- Therapeutic class
- Phosphodiesterase-5 Inhibitor
- Pharmacological class
- PDE5 Inhibitor
- Contraindications
- organic nitrates; severe hepatic impairment; severe cardiovascular disease
- Minor side effects
- headache; flushing; dyspepsia
- Moderate side effects
- nasal congestion; dizziness; visual changes
- Serious side effects
- priapism, requires immediate medical attention
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Alkem Laboratories Ltd
- Onset Time
- 30–60 minutes
- Duration
- 4–6 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Nitrates; Alpha Blockers; Ketoconazole
- Age restrictions
- Approved for adult men.
- Pregnancy and breastfeeding
- TGA Category B: Not for female use. Breastfeeding: Not applicable.
Patient summary
designed to support erectile capability to manage physical performance and alleviate pelvic vascular constriction.
Mechanism of action
Inhibits PDE5 to elevate cyclic GMP, relaxing pelvic smooth muscle to promote blood inflow.